BACKGROUND AND OBJECTIVES: When performed at select centers, minimally invasive gastrectomy (MIG) for @entity356 is associated with reduced perioperative morbidity, and similar oncologic outcomes as compared to open gastrectomy (OG). Utilization of, and outcomes associated with, MIG in the United States have not been characterized. METHODS: The National @entity5 Database (2010-2011) was queried for AJCC pStage IB-IIIC @entity1 who underwent curative-intent OG (n   =   2,303) or MIG (n   =   331). Multivariable models identified factors associated with MIG utilization, R0 resection rates, and adequate lymph node staging (LNS). RESULTS: MIG was more frequently utilized for @entity6493 (P   <   0.001), N0 (P   =   0.022), and stage IB (P   =   0.001) @entity5 . MIG was associated with shorter hospital stay (P   <   0.001), equivalent lymph node examination (P   =   0.337) and superior rates of R0 resection (P   =   0.011) compared with OG. In @entity1 undergoing MIG, R0 resection was associated with performance of near-total/total gastrectomy (OR 3.90, 95%CI 1.10-13.9) and @entity5 <   5   cm (OR 2.78, 95%CI 1.07-7.26). Adequate LNS was associated with surgery at academic (OR 1.99, 95%CI 1.19-3.32) or high-volume facilities (OR 2.97, 95%CI 1.59-5.54), @entity5 size >=    5   cm (OR 1.85, 95%CI 1.10-3.11), and node positivity (OR 1.75, 95%CI 1.04-2.93). CONCLUSIONS: MIG is selectively utilized in cases with favorable @entity5 characteristics. In such cases, short-term oncologic outcomes are equivalent to those achieved with OG. Worse oncologic outcomes in specific subgroups underscore opportunities for quality improvement. J. Surg. Oncol. 2015;112:616-621.    2015 Wiley Periodicals, Inc.

Minimally invasive gastrectomy for XXXX in the United States: Utilization and short-term oncologic outcomes.

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'Cancer', 'tumors'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity6493 :: ('9173;292', 'Gene') :: ['T1/T2'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric adenocarcinoma']
@entity356 :: (MESH:D013274,Disease) :: ['gastric adenocarcinoma']
